[Meta] the method development rule is doing its job and people should stop complaining
the method development rule is doing its job and people should stop complaining. Disagreement welcome, but bring a concrete alternative wording.
Why two honest labs report different numbers on the same vial.
Start with the gradient. A shallower slope holds compounds on the column longer and usually separates close-eluting species better. A steeper one gets you a faster run and a fatter peak. If a related substance elutes near the main peak, one method resolves it and reports it separately, the other absorbs part of it into the main peak.
Then integration. Where the baseline is drawn under a shoulder is a decision made by a person or by a piece of software configured by a person. It moves the number.
A point or two of spread between services on this assay is ordinary. Treating one lab as ground truth is how people end up in arguments with suppliers that neither side can win.
The system suitability argument, since it comes up whenever somebody posts a number without one.
Before the sample result means anything, the instrument has to be shown to be fit that day: replicate injections with an acceptable RSD on area, a tailing factor inside limits, adequate plate count, and a resolution check between the pair you care about.
None of that is exotic and all of it is routine in a laboratory that reports for a living. Its absence does not mean a number is wrong; it means the number is unanchored, and unanchored numbers should not be quoted to two decimal places on this board.
Reading a trace posted here, in the order I actually look at things.
Axes first — if the wavelength and the time axis are not labelled, I stop. Then the baseline: where has it been drawn, and does the drawing absorb anything. Then peak shape: fronting, tailing, a shoulder that never resolves. Then the blank, if one was run, for carryover.
Only after all of that do I look at the percentage, and by then I usually know how much weight it deserves. The number is the last thing on the page and the first thing everybody argues about, which is exactly backwards.
Research-use-only material is not approved for human use and nothing here should be read as a recommendation to use it.
best — the order this archive was captured in
Mass spectrometry answers identity. UV purity answers relative quantity under the run conditions. A document with one and not the other is answering half the question, and the half it answers should be stated.
Can you post the trace with the axes labelled?
Small fix — 214nm, not 210. It matters for the comparison you are making with the other run.
What wavelength, and what was the gradient?
Trace posted without axis labels — asked for a relabelled version rather than removing it.
Retention time shifted 0.4 minutes and I assumed the worst. It was the column temperature.
Chased a ghost peak for three weeks. It was the plumbing. It is always the plumbing.
Sent the same vial to Medutest and Janoshik. 99.6% against a claimed 99.0%. The difference was the gradient, not the material.
System suitability — repeat injections, tailing factor, plate count, RSD on area — is what tells you the instrument was fit for the measurement that day. Without it, the purity figure is unanchored.
reproducibility beats resolution if you only get one of them
214nm sees the peptide bond, 280nm sees the aromatics
Yes. Retention time is a hypothesis about identity. Mass is the answer.
Correcting myself upthread: I said the gradient was linear and looking again it has a hold in the middle.